SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-029260
Filing Date
2022-08-11
Accepted
2022-08-11 16:23:02
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10040517_10q.htm   iXBRL 10-Q 1909558
2 EXHIBIT 31.1 brhc10040517_ex31-1.htm EX-31.1 12188
3 EXHIBIT 31.2 brhc10040517_ex31-2.htm EX-31.2 12360
4 EXHIBIT 32.1 brhc10040517_ex32-1.htm EX-32.1 5139
5 EXHIBIT 32.2 brhc10040517_ex32-2.htm EX-32.2 5134
  Complete submission text file 0001140361-22-029260.txt   6783882

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA knte-20220630.xsd EX-101.SCH 36703
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE knte-20220630_cal.xml EX-101.CAL 54120
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE knte-20220630_def.xml EX-101.DEF 181160
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE knte-20220630_lab.xml EX-101.LAB 513495
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knte-20220630_pre.xml EX-101.PRE 330425
57 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040517_10q_htm.xml XML 1033513
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39743 | Film No.: 221156215
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences